Subscriber access provided by UNIVERSITY OF ADELAIDE LIBRARIES

Article
Characterization of the functional variance in MbtH-like
protein interactions with a nonribosomal peptide synthetase
Rebecca Anne Schomer, and Michael George Thomas
Biochemistry, Just Accepted Manuscript • DOI: 10.1021/acs.biochem.7b00517 • Publication Date (Web): 07 Sep 2017
Downloaded from http://pubs.acs.org on September 8, 2017

Just Accepted

“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a free service to the research community to expedite the
dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts
appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been
fully peer reviewed, but should not be considered the official version of record. They are accessible to all
readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered
to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published
in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just
Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor
changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers
and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors
or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Biochemistry is published by the American Chemical Society. 1155 Sixteenth Street

N.W., Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.
Page 1 of 48 Biochemistry

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23 TOC Figure
24
25 82x38mm (300 x 300 DPI)
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
 Biochemistry Page 2 of 48

1
2
3
4
5
6
7 Characterization of the functional variance in MbtH-like protein
8
9
10
11
interactions with a nonribosomal peptide synthetase.
12
13
14
15 Rebecca A. Schomer and Michael G. Thomas*.
16
17
18
19 * Corresponding Author: michael.thomas@wisc.edu
20
21
22 Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, 53706.
23
24
25 KEYWORDS: Nonribosomal peptide synthetases, MbtH-like proteins, Natural Product
26
27
28 Biosynthesis, Nonribosomal peptides.
29
30
31
32 ABSTRACT
33
34
35
36
Many nonribosomal peptide synthetases (NRPSs) require MbtH-like proteins (MLPs) for
37
38 solubility or for activation of amino acid substrate by the adenylation domain. MLPs are capable
39
40 of functional crosstalk with non-cognate NRPSs at varying levels. Using enterobactin
41
42
43 biosynthesis in Escherichia coli as a model MLP-dependent NRPS system, we use in vivo and in
44
45 vitro techniques to characterize how seven non-cognate MLPs influence the function of the
46
47 enterobactin NRPS EntF when the cognate MLP, YbdZ, is absent. Using a series of in vitro
48
49
50 assays to analyze EntF solubility, adenylation, aminoacylation and in vitro enterobactin
51
52 production, we show that interactions between MLPs and NRPSs are multifaceted and more
53
54
complex than previously appreciated. We separate MLP influence on solubility and function in a
55
56
57 manner that shows altered solubility is not indicative of a functional MLP/NRPS pair. Although
58
59
60
ACS Paragon Plus Environment 1
Page 3 of 48 Biochemistry

1
2
3
much of the functional variation among these noncognates can be explained by differences in
4
5
6 EntF affinity for an MLP or the extent an MLP alters EntF L-Ser affinity, we demonstrate that
7
8 MLPs can have a broader impact beyond solubility and adenylation. First, we show that a non-
9
10
11
cognate MLP can affect formation of L-Ser-S-EntF. Second, under in vitro conditions saturating
12
13 for substrate and MLP, enterobactin production remains compromised in the absence of an
14
15 appropriate MLP partner. These data suggest that we expand our investigations into how the
16
17
18 MLPs influence NRPS enzymology. A more detailed understanding of these influences will be
19
20 essential for downstream engineering of hybrid NRPS systems.
21
22
23
24
25
26
27 Nonribosomal peptide synthetases (NRPSs) employ a repetitive, modularly organized
28
29
30
enzymology to condense amino acids into the backbones of many natural products. NRPS
31
32 enzymology typically requires three core catalytic domains: an adenylation (A) domain, a
33
34 peptidyl carrier protein (PCP) domain, and a condensation (C) domain. The A domains recognize
35
36
37 and activate the appropriate amino acid as an amino acyl-AMP intermediate and then covalently
38
39 tether the amino acid onto partner PCP domains, forming a thioesterified aminoacyl-S-PCP
40
41 intermediate. The C domains catalyze amide-bond formation between neighboring aminoacyl-S-
42
43
44 PCP intermediates in a directional manner. We1 and others2,3 determined that within these core
45
46 catalytic domains, there are two classes of A domains: those that require an auxiliary protein
47
48
belonging to the MbtH-like protein (MLP) superfamily, and those that are MLP-independent.
49
50
51
52 MLPs are small, bacterial proteins that are nearly always encoded within a nonribosomal peptide
53
54 biosynthetic gene cluster. For example, MbtH, after which this protein superfamily is named, is
55
56 encoded by the eighth gene in the NRPS-encoding mycobactin biosynthesis gene cluster in
57
58
59
60
ACS Paragon Plus Environment 2
 Biochemistry Page 4 of 48

1
2
3
Mycobacterium tuberculosis H37Rv.4 Although the gene encoding MbtH was discovered nearly
4
5
6 20 years ago,4 the role MLPs play in NRPS enzymology has remained an enigma. Initial
7
8 analyses of pyoverdine biosynthesis showed the MLP-encoding gene, PA2412, to be involved in
9
10
11
the production of siderophore and required for Pseudomonas aeruginosa growth in iron-limited
12
13 medium.5 Further genetic evidence for their essentiality in producing an associated nonribosomal
14
15 peptide came from thorough genetic analyses of MLP-encoding genes in Streptomyces
16
17
18 coelicolor.6,7 In these studies, it was shown that deletion of the MLP-encoding gene in a targeted
19
20 gene cluster did not fully disrupt production of the associated nonribosomal peptide in a wild-
21
22 type S. coelicolor. In contrast, when all the MLP-encoding genes in this bacterium were deleted,
23
24
25 including the one associated with the metabolite of interest, metabolite production was abolished.
26
27 These genetic studies provided not only evidence for the importance of MLPs in producing
28
29
nonribosomal peptides, but also showed the ability of noncognate MLPs to functionally replace
30
31
32 each other at some level.
33
34
35 The first evidence that MLPs bind and influence the function of NRPSs came from the finding
36
37 that nikkomycin biosynthesis involved the function of a monomodular NRPS where the MLP
38
39
40 along with the A and PCP domains are fused as a single peptide.8,9 This observation was
41
42 overlooked until our group1 and the Walsh3 and Heide2 groups reported that MLPs influenced the
43
44
45
solubility of the associated NRPSs, along with their function. One of more important insights
46
47 from these data came from the analysis of EntF, an NRPS involved in enterobactin (ENT)
48
49 biosynthesis in E. coli.1,10–12 This NRPS can be overproduced and purified with or without its
50
51
52 MLP partner, YbdZ, providing a way to compare the kinetics of the enzyme purified under these
53
54 two conditions. Our data showed that when EntF was co-produced with YbdZ, it not only co-
55
56 purified with the MLP and had increased solubility, but the enzyme also had a higher affinity for
57
58
59
60
ACS Paragon Plus Environment 3
Page 5 of 48 Biochemistry

1
2
3
its amino acid substrate L-Ser. This was the first insight into how an MLP can directly influence
4
5
6 NRPS enzymology. More recent work has shown that the presence of YbdZ also has a minor
7
8 influence on A domain affinity for the co-substrate ATP.13
9
10
11 Despite observations that MLPs are essential to produce specific nonribosomal peptides and, that
12
13
14 in the absence of the MLP, the NRPS has reduced solubility and affinity for its substrate, a
15
16 mechanism for how MLPs have these impacts remains elusive. A clear understanding of this
17
18
19
mechanism is complicated by the finding that not all MLP/NRPS interactions are equal, even
20
21 within the same nonribosomal peptide biosynthetic pathway. For example, we have shown that
22
23 MbtH itself has different interactions with each of its NRPS partners involved in mycobactin
24
25
26 biosynthesis.14 MbtF and MbtE are completely insoluble without coproduction with MbtH, but
27
28 MbtB can be overproduced and purified without MbtH. Kinetic analysis of the two forms of
29
30 MbtB found they had equivalent kinetics for amino acid activation; thus, the only observed
31
32
33 impact of MbtH on MbtB is to enhance its solubility. These observations suggest there are three
34
35 forms of MLP-dependent NRPSs: 1) NRPSs that are completely dependent upon an MLP for
36
37 solubility and activity (e.g. MbtF, MbtE); 2) NRPSs that have increased solubility in the
38
39
40 presence of an MLP but do not require the MLP for amino acid activation (e.g. MbtB); and 3)
41
42 NRPSs that have increased solubility and superior kinetics for amino acid activation in the
43
44
45
presence an MLP (e.g. EntF). It should also be noted that even if a biosynthetic gene cluster
46
47 codes for an MLP, it does not necessarily mean all the A domains of the NRPS encoded by the
48
49 same gene cluster are MLP-dependent. For example, we have shown that in the viomycin,
50
51
52 capreomycin, and ENT biosynthetic pathways, at least one of the A domains of the associated
53
54 NRPSs is MLP-independent even though the associated gene cluster codes for an MLP.1
55
56
57
58
59
60
ACS Paragon Plus Environment 4
 Biochemistry Page 6 of 48

1
2
3
Several studies have attempted to gain insights into the mechanism and specificity of MLPs in
4
5
6 NRPS enzymology using structural biology. The first MLP-A structure, solved by Heide and
7
8 colleagues,15 was a didomain protein wherein the MLP was naturally fused to the N-terminus of
9
10
11
the A domain (an in cis MLP). The structure of this protein, SlgN1, revealed that the MLP/NRPS
12
13 interface does not fall near the substrate binding pocket, suggesting the impact of the MLP on A
14
15 domain substrate recognition is likely at a distance. The interactions between the MLP and A
16
17
18 domains were proposed to be driven by two highly conserved tryptophan residues of the MLP,
19
20 Trp25 and Trp35 (SlgN1 amino acid residue numbering), on the hydrophobic surface of the MLP
21
22 that form a pocket that accommodates Ala433 of the partner A domain.3,15 Using alignments of
23
24
25 A domains characterized as MLP-dependent or MLP-independent, it is proposed that the
26
27 presence of the alanine or proline residue at this position of the NRPS could be an indication of
28
29
an MLP-dependent A domain.15
30
31
32
33 Recently, Gulick and colleagues have reported structures of EntF with and without YbdZ, as well
34
35 as with a noncognate MLP, PA2412, from Pseudomonas aeruginosa.13,16 These structures
36
37 confirmed the location of the MLP/NRPS interface in the more common in trans MLP-
38
39
40 dependent NRPS is the same as that observed in the in cis SlgN1 structure. Furthermore, these
41
42 structures showed the MLP is not located in a region of the NRPS that would interfere with any
43
44
45
of the other domains of the NRPS (EntF domain structure is C-A-PCP-thioesterase).13
46
47 Surprisingly, a comparison of the structures of the A domains in EntF, EntF+YbdZ, and
48
49 EntF+PA2412 structures showed that the MLP had little to no influence on the conformation of
50
51
52 the A domain.13 The Schmeing group corroborated this work by reporting a structure of DhbF in
53
54 complex with its partner MLP that also showed no significant conformational changes from a
55
56 NRPS in the absence of an MLP; however, a decrease in the apparent molecular weight of DhbF
57
58
59
60
ACS Paragon Plus Environment 5
Page 7 of 48 Biochemistry

1
2
3
A domain complexed with an MLP versus the A domain alone suggest conformational changes
4
5
6 that are not captured by crystallization.17 Unfortunately, even with increasing amounts of
7
8 structural, biochemical and genetic data, the mechanism for how an MLP influences NRPS
9
10
11
catalysis is still unknown.
12
13
14 Finally, using the structural data and accumulated biochemical characterization, Gulick and
15
16 colleagues attempted to elucidate a method to identify MLP-dependence from protein sequence
17
18
19
using the sequence marker GEx10GYx10FxA/P.13 The critical Ala/Pro residue of the A domain
20
21 coordinated by the Trp pocket of the MLP lies just downstream of the conserved A6 motif
22
23 (GEx10GY) of A domains.18 However, a majority of A domains, regardless of whether they were
24
25
26 MLP-dependent or not, have a sequence that is compatible with MLP-NRPS interaction. The
27
28 only conclusion that can be made is that, if a bulky site chain is found in the A/P position, it may
29
30 be MLP-independent and the only clear evidence for MLP-dependence relies on biochemical
31
32
33 analysis of the NRPS.
34
35
36 We are interested in understanding both the specificity of an NRPS for its cognate MLP and how
37
38 the MLP influences NRPS enzymology. To this end, we have chosen to focus our efforts on the
39
40
41 ENT NRPS system in E. coli based on its simplicity, the genetic and biochemical tools readily
42
43 available for its analysis, and the availability of high resolution structures. The ENT NRPS is a
44
45 two-module system that contains only one MLP-dependent A domain that is contained in EntF
46
47
48 (Fig. 1). Furthermore, its natural MLP, YbdZ, is the only MLP encoded in the genome. EntF can
49
50 also be overproduced and purified without YbdZ,1 enabling the use of in vitro studies to evaluate
51
52
interactions between YbdZ and EntF, as well as interactions between EntF and noncognate
53
54
55 MLPs. These in vitro experiments can be coupled to in vivo analyses since strains of E. coli that
56
57 lack ybdZ cannot grow in iron-limited media (ILM).1 Here we present the in vivo and in vitro
58
59
60
ACS Paragon Plus Environment 6
 Biochemistry Page 8 of 48

1
2
3
analyses of ENT biosynthesis when this NRPS system contains or lacks its natural MLP, and
4
5
6 how the solubility and function of this system changes when non-cognate MLPs replace YbdZ.
7
8
9
10
11
12
13
14
15
16
17
18
19
20 Figure 1. Figure 1. Schematic of ENT NRPS domain structure. Light blue circles represent
21 NRPS domains, the red circle represents YbdZ, the MLP of the ENT system. Abbreviations: A,
22 adenylation; PCP, peptidyl carrier protein; C, condensation; Te, thioesterase.
23
24
25
26 Materials and Methods:
27
28
29 Bacterial strains and plasmid construction.
30
31
32
33 Bacterial strains used in this study are listed in Table S1. BW27783 ∆ybdZ was constructed using
34
35 the temperature sensitive plasmid pMAK705-ybdZ as previously described.1,19 All expression
36
37
38
plasmids were constructed using the primer incomplete polymerase extension (PIPE) cloning
39
40 method.20 Primers used to amplify vectors and inserts are listed in Supplementary Table 2. Genes
41
42 coding for MbtH, PA2412, Atu3678, MXAN_3118, BSU31959, CmnN and VioN were cloned
43
44
45 into pBAD33 with the ribosome binding site of pET37B.1 These constructs control the
46
47 expression of these genes by an arabinose-inducible promotor.21 These genes as well as those for
48
49 YbdZ, EntB and EntF were also cloned into pTEV5, an overexpression vector that fuses a
50
51
52 Tobacco etch virus (TEV) cleavage site in between the peptide and an N-terminal H6-tag.22
53
54 PA2412, Atu3878, BSU31959 and MXAN_3118 were cloned into pACYC-duet-1 for
55
56
overexpression of an untagged protein. Additional plasmids are referenced in Table S3. We note
57
58
59
60
ACS Paragon Plus Environment 7
Page 9 of 48 Biochemistry

1
2
3
that a recent reconstruction of the M. xanthus DK1622 genome has renamed the locus tags for
4
5
6 this bacterium and MXAN_3118 has been renamed MXAN_RS15115. However, at the time of
7
8 submission, there was no NCBI database entry for MXAN_RS15115. For this reason, we
9
10
11
continue to refer to this MLP as MXAN_3118 in this work.
12
13
14
15
16
17 Construction of phylogenetic tree for MLP proteins.
18
19
20 Protein sequences labeled as MbtH-like proteins were compiled from the NCBI protein database.
21
22
23 At the time of this study, there were approximately 9000 MLP homologs available in the NCBI
24
25 protein database. This data set was clustered based on percent identity using cdhit23 and
26
27 representative sequences were used for MLPs with 100% identity. Any sequences greater than
28
29
30 150 amino acids in length that remained in the data set were also eliminated unless they were
31
32 identified as fused MLP-A didomains. This limited the data set to 5,393 unique sequences and
33
34 the phylogenetic tree was constructed from the alignment of these unique sequences. Alignments
35
36
37 were created by MAFFT24 and FastTree25 was used to create the phylogenetic tree. The
38
39 Interactive Tree of Life (iTOL) was used to visualize the tree.26
40
41
42
43
44
45
46 Growth of BW27783 ∆ybdZ in iron-limiting media.
47
48
49 E. coli strains BW27783 or BW27783 ∆ybdZ were transformed with pBAD33 or pBAD33
50
51
52
containing ybdZ, mbtH, PA2412, Atu3678, MXAN_3118, BSU31959, cmnN, or vioN. For all
53
54 growth curves, each strain was grown in triplicate in LB with 34 µg mL-1 chloramphenicol for 8
55
56 hours at 30°C. Cells were washed in M9 minimal media (Teknova). Two hundred microliters of
57
58
59
60
ACS Paragon Plus Environment 8
 Biochemistry Page 10 of 48

1
2
3
4
M9 minimal media containing 0.4% (v/v) glycerol, 34 µg mL-1 chloramphenicol and 25 µM
5
6 ethylenediamine-N,N’-bis(2-hydroxyphenylacetic acid) (EDDHA) was inoculated with 1 µL of
7
8
9
each washed culture. For induction of pBAD33 promoter, arabinose was also added to the media
10
11 to a concentration of 0.001% (w/v). Cultures were grown in 96-well plate in a Biotek Eon plate
12
13 reader using orbital shaking at 580 rpm and 37°C. Absorbance at 600nm was recorded every 30
14
15
16 minutes for 48 hours. Each growth curve was done in triplicate and then averaged before being
17
18 plotted using GraphPad Prism (ver. 6.0h).
19
20
21
22
23
24 Co-overproduction of EntF with MLPs for solubility assay.
25
26
27
28 E. coli strain BL21(DE3) ybdZ::acc(IV) was transformed with pTEV-entF and pACYC-duet-1 or
29
30 pACYC-duet-1 containing an MLP-encoding gene (ybdZ, mbtH, PA2412, MXAN_3118,
31
32
Atu3678, BSU31959, vioN, or cmnN), selecting for growth in 100 µg mL-1 ampicillin and 34 µg
33
34
35 mL-1 chloramphenicol. Each strain was grown to saturation in 10 mL LB with ampicillin and
36
37 chloramphenicol and then subcultured into 1 L of the same media. These cultures were grown at
38
39
40 25 °C to an OD600 of 0.425 before being transferred to 16 °C for 1 hour. Isopropyl β-D-1-
41
42 thiogalactopyranoside (IPTG) was added to a final concentration of 60 µM and cells were shaken
43
44
45
at 200 rpm at 16 °C for 12 to 16 hours. Cells were harvested by centrifugation for 10 min at
46
47 6,640 x g and 100 mg of cells was resuspended in 1 mL of Buffer A. Buffer A contained 300
48
49 mM NaCl, and 20 mM Tris-HCl, pH 8. The cells were lysed by sonication at 20% power for 2
50
51
52 minutes with 1 second on, 1 second off pulses (Fischer Scientific Sonic Dismembrator Model
53
54 500). Cell-free extract was generated by centrifugation for 10 minutes at 16100x g. A total of 75
55
56 µg of protein in the cell-free extract was separated by SDS-PAGE (12.5% acrylamide) and
57
58
59
60
ACS Paragon Plus Environment 9
Page 11 of 48 Biochemistry

1
2
3
visualized with Coomassie blue staining to visualize the amount of soluble EntF. Samples were
4
5
6 also analyzed using Tris-Tricine-based SDS-PAGE (12% acrylamide) and Coomassie blue
7
8 staining to visualize the co-overproduced MLPs.
9
10
11 Detection of in vivo MLP levels by T7 tag monoclonal antibody.
12
13
14
15 E. coli BW27749 ∆ybdZ was transformed with pBAD33 containing each MLP-encoding gene
16
17 expressing an MLP with a C-terminal T7 tag. Construction of each pBAD-MLP-T7 expression
18
19 plasmid involved gBlocks (Integrated DNA Technologies) and restriction cloning (Table S4).
20
21
22 PA2412, Atu3678, BSU31959, cmnN and vioN were ligated into pBAD33 using the XbaI and
23
24 PstI restriction sites. The genes coding for YbdZ, MbtH and MXAN_3118 were ligated into
25
26
pBAD using XbaI and HindIII restriction sites. Each resulting expression strain was grown for 8
27
28
29 hrs in 2 mL LB with 34 µg/mL chloramphenicol. Cells were washed in M9 minimal media
30
31 (Teknova) and 100 µL was subcultured into 3 mL of M9 minimal media supplemented with
32
33
34
0.4% glycerol and 34 µg/mL chloramphenicol. When required, increased expression of the gene
35
36 coding for an MLP was induced by the addition of 0.001% (w/v) arabinose when the culture
37
38 reached an OD600 of 0.5 and then incubated at 37°C for 1 hr before harvesting. Cell pellets were
39
40
41 weighed and resuspended in 100 µL 1X Bugbuster® (Novagen) per 100 mg of cell paste.
42
43 Cultures were lysed for 10 minutes while gently rocking at room temperature. A total volume of
44
45
46 10 µL of cell extract from each sample was separated by SDS-PAGE and transferred to PDVF
47
48 membrane using a semi-dry apparatus for 30 min at 15V. Before transfer, the SDS-PAGE gel
49
50 and PDVF membrane were equilibrated in semi-dry transfer buffer containing 50 mM Tris-HCl,
51
52
53 40 mM glycine, 0.037% (w/v) SDS, 20% (v/v) MeOH, pH 8.3. The membrane was dried for 1 hr
54
55 at 37°C before a 1 hr incubation in PBS pH 7.4 with 2.5% (w/v) milk, 1% (v/v) Tween-20 and
56
57
58
1:5000 dilution of T7 monoclonal antibody-horseradish peroxidase conjugate. Membrane was
59
60
ACS Paragon Plus Environment 10
 Biochemistry Page 12 of 48

1
2
3
washed twice for 5 min in PBS before exposure to SuperSignal ® West Pico chemiluminescent
4
5
6 substrate (ThermoScientific).
7
8
9
10
11
12 Overproduction of proteins for purification.
13
14
15
16
E. coli BL21(DE3) ybdZ::acc(IV) was used as the background strain for all overproductions in
17
18 this study. All cultures were grown to saturation in LB supplemented with the appropriate drugs
19
20 and 10 mL was subcultured into each liter of LB used for overproduction. Strains containing
21
22
23 overexpression constructs for MLPs were grown in 3 L LB with 100 µg mL-1 ampicillin. The
24
25 strain containing only pTEV5-entF was grown in total of 12 L LB supplemented with 100 µg
26
27
28 mL-1 ampicillin. Strains for co-overproductions containing pTEV5-entF or pTEV5-entB with
29
30 pSU20-sfp, pACYC-duet-1-ybdZ or pACYC-duet-1-Atu3678 were grown in 6 L of LB
31
32
supplemented with 100 µg mL-1 ampicillin and 34 µg mL-1 chloramphenicol. All strains were
33
34
35 grown at 25°C to an OD600 of 0.425 before being transferred to 16 °C for one hour. IPTG was
36
37 added to a final concentration of 60 µM and cells were shaken at 200 rpm at 16°C 12 to 16
38
39
40 hours. Cells were harvested by centrifugation for 10 min at 6,641 x g and pellets were frozen at -
41
42 20 °C before purification.
43
44
45
46
47
48
49 Purification of MLPs.
50
51
52 MLPs were purified by nickel-affinity chromatography following a previously described
53
54 protocol.27 The 6x His-tag of each protein was then cleaved by TEV and uncleaved protein was
55
56
57
removed by a second round of nickel affinity chromatography as previously reported, but with
58
59
60
ACS Paragon Plus Environment 11
Page 13 of 48 Biochemistry

1
2
3
slight modification.14,22 Briefly, after purification by nickel affinity, fractions containing the
4
5
6 MLPs were dialyzed at 4 °C overnight with a 1:50 molar ratio of H6-TEV protease against
7
8 Buffer B, containing 50 mM NaCl, 50mM Tris-HCL, 5mM DTT, pH 7.9, to cleave the H6 tag.
9
10
11
The proteins were transferred to Buffer C, containing 25 mM NaCl, 50mM Tris-HCl at pH 7.9,
12
13 to remove DTT before the protein was passed through Ni-NTA resin for a second time. Resin
14
15 was removed by centrifugation and tagless protein was visualized by SDS-PAGE and Coomasie
16
17
18 blue staining. Each protein was concentrated using a Centriprep® centrifugal filter YM-3, flash
19
20 frozen using liquid nitrogen and stored a -80 °C. Only MLPs lacking an N-terminal his tag were
21
22 used for in vitro studies. The concentrations of the MLPs were determined using the calculated
23
24
25 molar extinction coefficients of the untagged proteins (YbdZ, 23,615 M-1cm-1; MbtH, 17,990 M-
26
1
27 cm-1; PA2412, 20,970 M-1cm-1; MXAN_3118, 20,970 M-1cm-1; Atu3678, 20,970 M-1cm-1;
28
29
BSU31959, 20,970 M-1cm-1; CmnN, 19,480 M-1cm-1; VioN, 19,480 M-1cm-1). Purified MLPs
30
31
32 are shown in Fig. S1.
33
34
35
36
37
38 Purification of apo-Ent, holo-EntF, holo-EntB, apo-EntF/YbdZ and apo-EntF/Atu3678.
39
40
41
42
For all overproductions of EntF, nickel affinity chromatography and H6-tag cleavage by TEV
43
44 protease were performed the same as the purification of the MLPs along, but with two additional
45
46 purification steps. After the second pass through Ni-NTA resin, protein was loaded onto a 5 mL
47
48
49 HiTrap® Q Sepharose FastFlow column (New England BioLabs) and, using a low-pressure
50
51 chromatography system, protein was eluted over a gradient from 100% Buffer C/0% Buffer D to
52
53 0% Buffer C/100% Buffer D over 80 minutes at a flow rate of 1 mL min-1. Buffer D contained
54
55
56 500 mM NaCl, 50 mM Tris-HCl, pH 7.9. Fractions containing EntF were identified by SDS-
57
58
59
60
ACS Paragon Plus Environment 12
 Biochemistry Page 14 of 48

1
2
3
PAGE and Coomassie blue staining. These fractions were pooled and concentrated to 1 mL
4
5
6 using a Centriprep YM-30 and dialyzed in Buffer C at 4 °C overnight. Finally, the sample was
7
8 loaded into a HiPrep 16/60 Sephracryl S-200 high-resolution column for size exclusion
9
10
11
chromatography. Using the low-pressure chromatography system, protein was eluted with buffer
12
13 C at a flow rate of 0.5 mL min-1. Fractions containing the protein of interest were identified by
14
15 SDS-PAGE and Coomassie blue staining. These fractions were pooled and concentrated in a
16
17
18 Centriprep® centrifugal filter YM-30 (Millipore). The samples were then flash frozen in liquid
19
20 nitrogen and stored at -80 °C until use. The concentration of purified EntB, EntE, and EntF
21
22 proteins were calculated using the calculated molar extinction coefficients. For, EntF/YbdZ and
23
24
25 EntF/Atu3678, the protein concentration was calculated using a calculated molar extinction
26
27 coefficient of a fusion protein of EntF-MLP (EntF-YbdZ, 207,640 M-1cm-1; EntF-Atu3678,
28
29
205,120 M-1cm-1). Subsequent analysis of the EntF/MLP complex by sample dilution followed
30
31
32 by SDS-PAGE, commassie blue staining, and comparison to a known quantity of purified EntF
33
34 confirmed the EntF concentration in the EntF/YbdZ and EntF/Atu3678 complexes.
35
36
37
38
39
40
41 Radiolabeled ATP/PPi exchange assays.
42
43
44 ATP/PPi exchange assays were performed as previously described.1,14 Each 100 µL assay
45
46 contained 75 mM Tris-HCl pH 7.5, 10 mM MgCl2, 5 mM dithiothreitol (DTT), 3.5 mM ATP pH
47
48
49 7.5, 1mM NaPPi pH 7, [32P] PPi (0.9 Ci mol-1, PerkinElmer), and varying concentrations of
50
51 enzyme, MLP, and L-Ser. All assays were performed at room temperature in the linear range of
52
53
54
enzyme concentration and less than 10% substrate to product conversion. To determine the
55
56 kinetic parameters of EntF interaction with each MLP, the L-Ser concentration was held constant
57
58
59
60
ACS Paragon Plus Environment 13
Page 15 of 48 Biochemistry

1
2
3
at 0.2 mM, while the concentration of MLP was varied. MLP concentrations were 0.05, 0.1,
4
5
6 0.25, 0.5, 0.75, 1.0 and 2.0 µM. To determine the pseudo-first order kinetic parameters of L-Ser
7
8 activation, the ATP concentration was held constant, while the L-Ser concentration was varied.
9
10
11 For kinetics of L-Ser activation, MLP concentration was held at 5x the kd determined in this
12
13 study and the reaction was incubated in the reaction mixture for 10 minutes before the addition
14
15
of amino acid substrate. For assays of EntF without an MLP and with CmnN or VioN, L-Ser
16
17
18 concentrations used were 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 7.5, and 10 mM.
19
20 For assays of EntF/YbdZ or EntF with YbdZ, MbtH, PA2412, MXAN_3118, or BSU31959, L-
21
22
23
Ser concentrations used were 0.01, 0.025, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.5, 0.6, 0.8,
24
25 and 1 mM. Kinetic parameters were determined using nonlinear regression analysis (GraphPad
26
27 Prism ver. 6.0h). All kinetic studies were performed in the linear range of the assay for substrate
28
29
30 to product conversion (< 10% substrate to product conversion) and EntF concentration.
31
32
33
34
35
36 Formation of L-Ser-S-EntF.
37
38
39 Formation of L-Ser-S-EntF was monitored using 30 µL reaction mixtures containing 50 mM
40
41
42 Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM Tris-(2-carboxyethlyphosphine) (TCEP), 20 µM EntF, 1
43
44 µM Sfp, 500 µM Coenzyme A, 5 mM ATP, pH 7 and 0.1 mM [14C]-L-Ser (100mCi mmol-1,
45
46
47 Perkin Elmer).27 Reactions were incubated for 2 hours at 37 °C to phosphopantetheinylate EntF
48
49 before the addition of ATP, [14C]-L-Ser or MLP. Five times the kd of EntF for each MLP
50
51
52 determined by ATP-PPi assays was used as the concentration of the MLP in this assay. After
53
54 phosphopantetheinylation, ATP and MLP were added to the assay mixtures and incubated for 5
55
56 minutes at room temperature before the addition of [14C]-L-Ser. Reactions were stopped after 40
57
58
59
60
ACS Paragon Plus Environment 14
 Biochemistry Page 16 of 48

1
2
3
4
minutes by aliquoting 10 µL of the reaction mixture into an equal volume of 2x sample buffer
5
6 containing 60 mM Tris-HCl, pH 6.8, 10% (w/v) SDS, 50% (v/v) glycerol, and 0.4% (w/v)
7
8 bromophenol blue and 5 µL was loaded onto an SDS-PAGE gel. Protein was visualized by
9
10
11 Coomassie blue staining before the gel was dried and exposed to a phosphorimaging screen for
12
13 24 hours. The gels were exposed to the phosphorimaging screen alongside a set of known [14C]
14
15
16 standards to generate a standard curve for pixels to disintegrations per minute used to quantify
17
18 [14C] L-Ser-S-EntF produced.
19
20
21
22
23
24 In vitro reconstitution of ENT production:
25
26
27
28 Production of ENT in vitro was based off of a previously published protocol12 and monitored by
29
30 chrome azurol S (CAS) liquid assays.28 Each 200 µL reaction mixture contained 75 mM Tris-
31
32
33 HCl pH 7.5, 10 mM ATP, 5 µM TCEP, 15 µM MgCl2, 300 nM EntE, 5 nM holo-EntF, 5 µM
34
35 holo-EntB and MLPs to a concentration 5x the kd determined by ATP-PPi exchange assays in this
36
37 study. Phosphopantetheinylation of EntF and EntB was achieved in vivo by co-overproduction of
38
39
40 EntF and EntB with Sfp. EntE purification was previously published1 and stored at -80°C until
41
42 use. L-Ser and 2,3-dihydroxybenzoate (2,3-DHB) were added to final concentrations of 500 µM
43
44
45 and 10 mM, respectively, to initiate the reaction. Reactions lacking EntB were performed as a
46
47 control. Assays were incubated at 37 °C until 30 µL of sample reaction was aliquoted into 120
48
49
50 µL of CAS reagent to stop the reaction at 15 minute intervals. CAS and reaction mixtures were
51
52 incubated at room temperature for 5 minutes before the reciprocal absorbance at 630 nm was
53
54 measured.
55
56
57
58
59
60
ACS Paragon Plus Environment 15
Page 17 of 48 Biochemistry

1
2
3
LC/MS analysis of in vitro ENT biosynthesis products.
4
5
6
7 Reaction mixtures were prepared exactly as for the in vitro monitoring of ENT production by
8
9 CAS reagent. Samples were incubated at 37 °C for 60 minutes and quenched by the addition of
10
11 equal volume 1mM HCl. ENT and byproducts were removed by ethyl acetate extraction. A
12
13
14 volume of 750 µL ethyl acetate was added to the quenched reaction. From the ethyl acetate layer,
15
16 500 µL was removed and concentrated by evaporation in an Eppendorf vacufuge. The remaining
17
18
19 residue was resuspended in 50 µL in 30% acetonitrile in H2O and 10 µL of each sample was
20
21 analyzed by ultra-high-performance liquid chromatography (UHPLC) coupled with mass
22
23
24 spectrometry (MS). The samples were separated on a ZORBAX Eclipse XDB-C18 column
25
26 (Agilent, 2.1 x 150 mm with a 1.8 µM particle size). Before every run, the system was
27
28
29 equilibrated for 5 min at 0.5% (v/v) formic acid (FA) in 20% acetonitrile. A linear gradient of
30
31 0.5% FA in 20% to 100% acetonitrile was delivered over 15 minutes by a VanquishTM UHPLC
32
33 system (Thermo Scientific) with a flow rate of 0.2 mL min-1. The gradient was followed by an
34
35
36 isocratic step at 100% acetonitrile in 0.5% FA for 5 min. The UHPLC system was coupled to a Q
37
38 Exactive hybrid quadrupole OrbitrapTM MS (Thermo Scientific). For electrospray ionization, the
39
40 ion voltage was set at -3.5 kV in negative mode. The parent ion of the highest intensity was
41
42
43 fragmented in the ion trap mass spectrometer. Data analysis was performed using XcaliburTM
44
45 (ThermoFisher Scientific) and Maven29 software.
46
47
48
49
50
51
52 Results and Discussion
53
54
55 Noncognate MLPs can functionally replace YbdZ in vivo to varying extents.
56
57
58
59
60
ACS Paragon Plus Environment 16
 Biochemistry Page 18 of 48

1
2
3
We targeted seven MLPs from diverse sources to test their ability to functionally replace YbdZ
4
5
6 in our model NRPS/MLP system. These MLPs map to several phylogenetically diverse lineages
7
8 (Fig. S2) and are associated with NRPS systems that produce distinct metabolites. The MLPs
9
10
11
included in this study, besides YbdZ associated with ENT biosynthesis in E. coli,1 include MbtH
12
13 associated with mycobactin biosynthesis in M. tuberculosis str. H37Rv,4 PA2412 associated with
14
15 pyoverdine biosynthesis in P. aeruginosa PAO1,5 Atu3678 associated with siderophore
16
17
18 biosynthesis in Agrobacterium fabrum str. C58,30 BSU31959 associated with corynebactin
19
20 biosynthesis in Bacillus subtilis strain 168,31 MXAN_3118 an orphan MLP from Myxococcus
21
22 xanthus DK1622,32 VioN associated with viomycin biosynthesis in Streptomyces sp. strain
23
24
25 ATCC11863,33 and CmnN associated with capreomycin biosynthesis in Saccharothrix mutabilis
26
27 subsp. capreolus.34
28
29
30 The gene coding for each MLP was cloned into a pBAD33 vector and transformed into the E.
31
32
33 coli strain BW27749 ∆ybdZ. We assessed whether the resulting strains were able to grow in iron-
34
35 limited medium (Fig. 2), which contained 25 µM EDDHA as a competing iron chelator. The
36
37
38 presence of MbtH or PA2412 restored growth of BW27749 ∆ybdZ to a level comparable to that
39
40 observed for YbdZ. In contrast, VioN or CmnN had similar growth characteristics to the empty-
41
42 vector control. Strains carrying Atu3678, BSU31959, and MXAN_3118 had varying levels of
43
44
45 growth in ILM, but all three MLPs failed to enable growth at a level similar to that observed
46
47 when YbdZ was present.
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment 17
Page 19 of 48 Biochemistry

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22 Figure 2. Analysis of complementation for ∆ybdZ by various noncognate MLPs. Growth curves
23 for strains containing pBAD33 with No MLP, cmnN or vioN are superimposed along the
24 baseline. Data shown are means of triplicate, independent samples with standard deviation
25 shaded.
26
27
28
29
30
One hypothesis for the observed differences in complementation is the varying levels of amino
31
32
33 acid identity or similarity the noncognate MLPs have with YbdZ. Based on amino acid sequence
34
35 alignments, this does not appear to be the case since the ability to complement for the loss of
36
37
38
YbdZ does not correlate to similarity of the MLP to YbdZ (Fig. 3a). In fact, despite having
39
40 reduced or no ability to complement, BSU31959, CmnN, and VioN shared more amino acid
41
42 identity with YbdZ than PA2412 and Atu3678 (Fig. 3b), even though the latter were more
43
44
45 efficient at replacing YbdZ.
46
47
48 Several structures of MLPs in complex with an NRPS have been published, allowing a more
49
50 focused comparison of the MLP residues likely to interact with the NRPS.13,15,17 Residues
51
52
53 involved in NRPS-MLP interaction in these structures were cross-referenced with the sequence
54
55 alignments (Fig. 3a). Among these residues, there is significant commonality between functional
56
57 and nonfunctional MLPs. Despite this similarity at the interface, there are obvious functional
58
59
60
ACS Paragon Plus Environment 18
 Biochemistry Page 20 of 48

1
2
3
differences among the MLPs resulting in the observed gradation of growth phenotypes. This
4
5
6 incongruency between functionality and sequence similarity may imply that the overall
7
8 topography of the MLP/NRPS interface, rather than a specific set of residues, allows for the
9
10
11
MLP and NRPS to interact functionally in vivo. A compromised ability to complex correctly
12
13 with a partner MLP due to topographical incompatibilities could lead to a variety of impacts on
14
15 NRPS solubility or enzymology.
16
17
18
19
20
21
22
23
24
25
26
27
28

MXAN_3118
BSU31959

29
Atu3678
PA2412

B.

CmnN
30
MbtH
YbdZ

VioN
31
32
33 YbdZ 35% 22% 19% 29% 17% 26% 27%
34
35 MbtH 36% 41% 36% 46% 35% 42% 44%
36
37 PA2412 25% 41% 53% 38% 56% 58% 51%
38
Atu3678 22% 37% 53% 36% 41% 53% 56%
39
40
BSU31959 29% 46% 38% 36% 35% 40% 43%
41
42 MXAN_3118 20% 35% 56% 41% 36% 56% 48%
43
44 CmnN 26% 42% 58% 53% 42% 56% 65%
45
46 VioN 27% 44% 52% 57% 44% 51% 73%
47
48
49
50 Figure 3. (A) MLP amino acid sequence alignments. Residues implicated in protein-protein
51 interactions from structural studies of EntF/MLP complexes (pink) and didomain (MLP-
52
53
adenylation domain) SlgN1 (green) are highlighted. (B) Amino acid identity (upper tier) and
54 amino acid similarity (lower tier) comparisons for the MLPs included in this study.
55
56
57
58
59
60
ACS Paragon Plus Environment 19
Page 21 of 48 Biochemistry

1
2
3
Varying in vivo levels of the MLPs do not fully explain differential complementation.
4
5
6
7 Immunoblotting was used to investigate whether differences in the in vivo levels of the MLPs
8
9 explained the varying degrees of complementation. A polyclonal antibody against YbdZ was
10
11 only able to detect YbdZ, MbtH, and MXAN_3118; thus, it could not be used to compare the in
12
13
14 vivo levels of all the MLPs. In an attempt to circumvent this issue, all of the pBAD33-MLP
15
16 expression plasmids were reconstructed to produce an MLP with a C-terminal T7 tag.
17
18
19
Commercially available monoclonal antibodies to the T7 tag were then used in immunoblotting
20
21 experiments in an effort to detect the in vivo levels of the MLP-T7 fusion proteins. Importantly,
22
23 all of the MLP-T7-expression constructs resulted in complementation results consistent with
24
25
26 those observed with the untagged versions shown in Fig. 2.
27
28
29 We assessed the in vivo MLP-T7 levels when the constructs were grown in M9 minimal media
30
31 containing glucose as the carbon source. We do not detect a growth defect in a ∆ybdZ strain in
32
33
34
this medium. Immunoblotting did not detect any MLP-T7 unless arabinose was added to increase
35
36 the expression of the genes from the pBAD promoter. Under these media and expression
37
38 conditions, we detected comparable levels of YbdZ-T7, MbtH-T7, MXAN_3118-T7,
39
40
41 BSU31959-T7, and CmnN-T7, with lower levels of VioN-T7 (Fig. S3). Surprisingly, we failed
42
43 to detect any PA2412-T7 or Atu3678-T7 even though these constructs compensated for the loss
44
45 of YbdZ. At this time, it is unclear why these proteins are not detectable, yet they are able
46
47
48 complement for the loss of YbdZ.
49
50
51 These results also show that the MLPs that fail to fully compensate for the loss of YbdZ can be
52
53 produced at higher levels in the cells than when relying on the background expression from the
54
55
56 pBAD promoter. Reassessing complementation in ILM when increasing expression of the MLP
57
58
59
60
ACS Paragon Plus Environment 20
 Biochemistry Page 22 of 48

1
2
3
genes found only MXAN_3118 gained more ability to compensate for the loss of YbdZ (Fig.
4
5
6 S4). Also, increased expression of ybdZ did not enhance the growth of the ∆ybdZ strain,
7
8 suggesting the background level expression of ybdZ from the pBAD promoter is efficient in
9
10
11
providing enough of this MLP for ENT production under these growth conditions. Together,
12
13 these data suggest the failure of BSU31959, CmnN, and VioN to fully replace YbdZ in vivo was
14
15 unlikely to be due solely to low in vivo levels of these proteins.
16
17
18
19
MLPs influence EntF solubility to varying levels.
20
21
22 We hypothesized that one explanation for the observed differences in complementation was a
23
24 variation in the ability of an MLP to influence the solubility of EntF. This hypothesis was based
25
26
on the consistent finding of increased solubility of MLP-dependent NRPSs when these enzymes
27
28
29 are overproduced with a partner MLP.1–3,11,14,35 To investigate how the solubility of EntF was
30
31 affected in the presence of different MLPs, we overproduced EntF in E. coli BL21(DE3)
32
33
34
ybdZ::aac(3)IV in the presence or absence of each of the targeted MLPs and assessed the level of
35
36 EntF solubility by SDS-PAGE and Coomassie blue staining of soluble protein in cell-free
37
38 extracts (Fig. 4). As we previously reported,1 EntF solubility is significantly improved when co-
39
40
41 overproduced with its cognate MLP, YbdZ. Here, we found that EntF solubility does not always
42
43 correlate with the in vivo complementation data for a given noncognate MLP (Fig. 2). For
44
45 example, PA2412 is capable of restoring growth in BW27749 ∆ybdZ in ILM to levels
46
47
48 comparable to YbdZ (Fig. 2), but fails to show enhanced EntF solubility when the two proteins
49
50 were co-overproduced (Fig. 4). Using this same PA2412 overexpression construct, we
51
52
determined that PA2412 was required for solubility of three of the four adenylation-peptidyl
53
54
55 carrier protein domains of PvdL from P. aeruginosa (Fig. S5). Furthermore, each MLP could be
56
57 detected in the soluble fraction of these samples at levels at least comparable to YbdZ (Fig. S6).
58
59
60
ACS Paragon Plus Environment 21
Page 23 of 48 Biochemistry

1
2
3
Based on those data, we concluded that the low solubility of EntF was not due to a failure of our
4
5
6 PA2412 overexpression construct to overproduce a functional MLP, rather PA2412 does not
7
8 increase the solubility of EntF under these conditions. In contrast to PA2412, neither CmnN nor
9
10
11
VioN restored growth of E. coli ∆ybdZ in ILM, but both resulted in significantly more EntF in
12
13 the soluble fraction of the cell extracts when the NRPS was coproduced with these MLPs (Fig.
14
15 4), although VioN may enable a lower level of soluble EntF compared to CmnN. The remaining
16
17
18 MLPs (MbtH, MXAN_3118, Atu3678, and BSU31959) all enabled increased EntF solubility
19
20 compared to the no-MLP control, with BSU31959 resulting in slightly lower EntF levels. These
21
22 data indicate that the effects MLPs have on NRPS solubility and activity are separable.
23
24
25 Unfortunately, repeated attempts to detect chromosomally encoded EntF using monoclonal
26
27 antibodies to amino acid tags introduced into the coding region of either the 5' or 3' end of entF
28
29
were not successful; thus, we were unable to assess EntF solubility under physiologically
30
31
32 relevant conditions.
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49 Figure 4. Analysis of EntF solubility when co-overproduced with MLPs. Equal amounts of total
50
51
protein (75µg) were loaded for each sample on a SDS-PAGE (10% polyacrylamide) gel and
52 stained with Coomassie blue. This gel is representative of multiple experimental replicates.
53
54
55
56
57 Defining the Kd for binding of noncognate MLPs to EntF by in vitro reconstitution of complexes.
58
59
60
ACS Paragon Plus Environment 22
 Biochemistry Page 24 of 48

1
2
3
To gain further insight into the observed differences in complementation and EntF solubility, we
4
5
6 characterized the adenylation activity of the EntF and MLP complexes in vitro. We will refer to
7
8 the different forms of EntF as either EntF (overproduced and purified independently of an MLP)
9
10
11
or EntF/MLP (co-overproduced with an MLP). When an MLP is added to EntF, this form of the
12
13 NRPS will be referred to as EntF+MLP. Consistent with prior reports by us1 and Gulick and
14
15 colleagues,13 our current study found that the impact YbdZ has on the activation of L-Ser is
16
17
18 predominantly in enhancing the affinity of the enzyme for the amino acid, as noted by the
19
20 approximately 10-fold lower Km and a minimal impact on the kcat (Table 1). We exploited the
21
22 difference in Km to determine the Kd for the binding of YbdZ to EntF. Briefly, we set the
23
24
25 concentration of L-Ser to 200 µM, which is approximately 10-fold below the Km determined for
26
27 EntF but near the Km of EntF/YbdZ, to maximize the differences in the rate of L-Ser activation
28
29
30 by the two forms of the NRPS. We then added increasing concentrations of purified YbdZ to the
31
32 EntF reaction and monitored the increase in the reaction rate. Plotting the rate of the reaction
33
34 versus YbdZ concentration enabled us to then use non-linear regression analysis to define the Kd
35
36
37 for the binding of YbdZ to EntF (Table 1). We then determined the kinetics of L-Ser activation
38
39 of the reconstituted EntF+YbdZ complex when YbdZ was added at a concentration five-fold
40
41
higher than the Kd. These data showed that the kinetics of L-Ser activation by EntF+YbdZ were
42
43
44 restored to levels comparable to EntF/YbdZ (Table 1). Since the kinetic parameters of
45
46 EntF+YbdZ and EntF/YbdZ are comparable, we presumed the reconstituted EntF+YbdZ
47
48
49
complex is relevant to the EntF/YbdZ complex formed in vivo. Therefore, we could use this
50
51 reconstitution system to test the hypothesis that the observed differences in functional
52
53 replacement of YbdZ by noncognate MLPs is due to variation in the binding affinities of these
54
55
56 proteins for EntF. We note that repeated attempts to use alternative methods (differential
57
58
59
60
ACS Paragon Plus Environment 23
Page 25 of 48 Biochemistry

1
2
3
scanning fluorimetry or isothermal titration calorimetry) to determine the Kd for binding of YbdZ
4
5
6 to EntF gave uninterpretable results, necessitating the use of the approach outlined above.
7
8
9 Using the same method for determining the Kd for binding of YbdZ to EntF, we probed the
10
11 interactions between EntF and the noncognate MLPs. We found that all the noncognate MLPs,
12
13
14 with the exception of Atu3678, had an influence on the reaction rate of EntF and allowed us to
15
16 define a Kd for each MLP (Table 1). As observed with the solubility studies, the differences in
17
18
19
the Kd for binding of the MLPs to EntF did not correlate with the in vivo complementation
20
21 studies. For example, CmnN and VioN both had Kd values similar to YbdZ, but neither could
22
23 functionally replace YbdZ in vivo for ENT production. While the results were not consistent
24
25
26 with the complementation studies, they were consistent with the observed influence on EntF
27
28 solubility. The MLP with the highest Kd value (PA2412) resulted in the lowest levels of EntF
29
30 solubility (Fig. 4). The next two highest Kd values belonged to BSU31959 and VioN, both of
31
32
33 which resulted in slightly reduced EntF solubility relative to YbdZ (Fig. 4). Interestingly, the two
34
35 MLPs with the lowest Kd values (MbtH and CmnN) both influenced EntF solubility but had
36
37 opposite results in growth studies with MbtH fully complementing for the loss of YbdZ and
38
39
40 CmnN failing to show any level of complementation.
41
42
43 Kinetics of L-Ser activation by EntF+MLP complexes
44
45
46 With the Kd values determined, we could address whether the EntF+MLP complexes have
47
48
49 different kinetics of L-Ser activation, potentially explaining differences in in vivo
50
51 complementation. Each MLP was added to a reaction at a concentration five-fold higher than the
52
53 respective Kd. The kinetics of L-Ser activation using standard ATP/PPi exchange assays were
54
55
56 then determined. As noted above, the addition of YbdZ to the reaction restored the kinetics of
57
58
59
60
ACS Paragon Plus Environment 24
 Biochemistry Page 26 of 48

1
2
3
EntF-catalyzed L-Ser activation to levels comparable to those of the EntF/YbdZ complex (Table
4
5
6 1). Based solely on the kinetic data, the noncognate MLPs fell into two groups. EntF+MbtH,
7
8 EntF+PA2412, EntF+MXAN_3118, and EntF+BSU31959 all had kcat/Km values approximately
9
10
11
half of that observed for EntF+YbdZ, with the decrease in these values attributable mainly to a
12
13 doubling the Km of EntF for L-Ser (Table 1). In contrast, EntF+CmnN and EntF+VioN each
14
15 showed kinetic parameters more similar to EntF lacking an MLP (Table 1). This division did
16
17
18 not, however, correlate entirely with the in vivo complementation data. The failure of either
19
20 CmnN or VioN to functionally replace YbdZ in vivo may be due solely to the poor affinity of the
21
22 resulting NRPS+MLP complex for L-Ser (Table 1). Metabolomics has determined that when E.
23
24
25 coli is growing on glycerol, as in the current complementation study, the intracellular
26
27 concentration of L-Ser is approximately 150 µM.36 This is almost 10-fold below the Km of
28
29
30 EntF+CmnN and EntF+VioN for L-Ser. Interestingly, both CmnN and VioN enable EntF to be
31
32 more soluble, but these protein-protein interactions presumably fail to hold EntF in the correct
33
34 conformation to positively influence the Km for L-Ser. Alternatively, MbtH and PA2412 were
35
36
37 able to efficiently replace YbdZ and enable growth of BW27783 ∆ybdZ in ILM. These results
38
39 suggest a doubling of the Km for L-Ser does not impact the enzymology enough to inhibit
40
41
growth, yet BSU31959 poorly replaces YbdZ in vivo despite having kinetic parameters
42
43
44 comparable to EntF+MbtH or EntF+PA2412 complexes (Table 1). This suggested that the
45
46 reason for the failure of BSU31959 to fully replace YbdZ in vivo was due to something other
47
48
49
than L-Ser activation.
50
51
52 The failure to detect any impact of Atu3678 addition on the activity observed with EntF,
53
54 suggests that a functional EntF+Atu3678 complex cannot be formed in vitro. We hypothesized
55
56
57
this based on the findings that Atu3678 does complement for the loss of YbdZ in growth studies
58
59
60
ACS Paragon Plus Environment 25
Page 27 of 48 Biochemistry

1
2
3
(Fig. 2) and enables more soluble EntF to be detected in cell free extracts (Fig. 4), but fails to
4
5
6 impact EntF enzymology after overproduction and purification independent of EntF. To test
7
8 this, we co-overproduced and purified an EntF/Atu3678 complex (Fig. S9) and determined the
9
10
11
kinetic parameters for L-Ser activation (Table 1). The kinetic parameters of EntF/Atu3678 were
12
13 more similar to EntF/YbdZ than EntF, leading us to conclude that production of functional
14
15 EntF+Atu3678 requires co-production of these proteins. Since there is no way to control Kd
16
17
18 effects using the co-purified complex and due to our inability to reconstitute an EntF+Atu3678
19
20 interaction in vitro, this MLP was not characterized further.
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment 26
 Biochemistry Page 28 of 48

1
2
3
4
5
6
7
8 Table 1. Kinetics for EntF copurified or reconstituted with MLPsa.
9
10
11 Km(L-Ser) kcat kcat/ Km
12 Kd(MLP)
Protein complex:
13
14 (nM) (µ
µM) (s-1) (M-1 s-1)
15
16
17 EntF/YbdZ - 149±58 0.95±0.1 6375
18
19
20 EntF - 1029±171 0.84±0.05 816
21
22
EntF+YbdZ 186±69 116±22 0.88±0.04 7858
23
24
25 EntF+MbtH 54.6±8 229±31 0.74±0.04 3231
26
27
28 EntF+PA2412 358±95 397±94 1.21±0.06 3047
29
30
31 EntF+MXAN_3118 166±29 303±42 1.37±0.08 4521
32
33
34 EntF+BSU31959 310±69 310±45 1.14±0.07 3677
35
36
37 EntF+CmnN 150±7 1051±244 0.35±0.02 333
38
39 200±63 1317±119 1.20±0.04 911
EntF+VioN
40
41
42 EntF/Atu3678 - 299.7±85 1.17±0.11 3913
43
44
45 a
Data shown in graphical form in Fig. S7 and S8.
46
47
48
49
Analysis of aminoacylation by EntF+MLP complexes.
50
51
52 The observation that EntF+BSU31959 has L-Ser activation kinetics similar to other EntF+MLP
53
54 complexes, but fails to functionally replace YbdZ in vivo led us to investigate whether this MLP
55
56
compromises EntF in aminoacylation of the PCP domain. To measure aminoacylation, we first
57
58
59
60
ACS Paragon Plus Environment 27
Page 29 of 48 Biochemistry

1
2
3
phosphopantetheinylated the purified EntF in vitro using the phosphopantetheinyltransferase,
4
5
6 Sfp. Since the same EntF preparation was used in all reactions, it is reasonable to assume that
7
8 observed differences between EntF+MLP complexes would not be due to differences in levels of
9
10
11
phosphopantetheinylation. The phosphopantetheinylated EntF was incubated with ATP, [14C]-L-
12
13 Ser, and the targeted MLP for a set amount of time and the amount of L-Ser-S-EntF formed was
14
15 detected and quantified using SDS-PAGE followed by phosphorimaging (Fig. 5). The
16
17
18 concentration of [14C]-L-Ser could only be added at levels comparable to the Km of L-Ser for
19
20 EntF+YbdZ (100 µM) because of limitations in the specific activity of commercially available
21
22
23
[14C]-L-Ser. We observed a maximal EntF-S-L-Ser level of approximately 50% in the presence
24
25 or absence of YbdZ, consistent with prior EntF/YbdZ studies.37 While we observed EntF
26
27 requiring additional time to form the EntF-S-L-Ser intermediate compared to EntF+YbdZ, an
28
29
30 accurate rate was difficult to determine because of the limitation in the sensitivity of the assay.
31
32 Due to this, we determined a time at which the levels of EntF aminoacylation were similar
33
34 between EntF and EntF+YbdZ and used an end-point assay to assess the level of aminoacylation
35
36
37 by each EntF+MLP complex. This approach did not lend itself to determining the rate of EntF-S-
38
39 L-Ser formation, rather it only evaluated whether an EntF+MLP complex forms the
40
41
aminoacylated intermediate at a level than either EntF or EntF+YbdZ under these assay
42
43
44 conditions.
45
46
47 EntF+MbtH, EntF+PA2412, EntF+MXAN_3118 and EntF+VioN showed equivalent
48
49 aminoacylation levels to both EntF+YbdZ and EntF. In contrast, the EntF+BSU31959 complex
50
51
52 failed to aminoacylate at a level comparable to EntF with or without the MLP. This suggests
53
54 BSU31959 holds EntF in a conformation that negatively impacts EntF aminoacylation (Fig. 5).
55
56
57
These data offer an explanation for why BSU31959 cannot complement for the loss of YbdZ in
58
59
60
ACS Paragon Plus Environment 28
 Biochemistry Page 30 of 48

1
2
3
vivo despite positively influencing both the solubility and kinetics of EntF adenylation (Fig. 4 &
4
5
6 Table 1). The EntF+CmnN complex is also moderately reduced in its ability to form the
7
8 aminoacylated intermediate. These data are the first direct evidence of an MLP having an impact
9
10
11
on a step in NRPS catalysis other than amino acid activation.
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33 Figure 5: Formation of [14C]-L-Seryl-S-EntF after 40 minutes of incubation at RT. EntF was
34
phosphopantetheinylated in vitro prior to incubation with [14C]-L-Ser and MLPs. Data shown are
35
36 the means with standard deviation from triplicate assays. Asterisk indicates statistically
37 significant difference (p=0.0194) using an unpaired t-test. ANOVA statistical analysis also
38 indicated a statistically relevant result.
39
40
41
42
43 Influence of MLPs on the in vitro rate of ENT production.
44
45
46
Our data investigating A domain-associated activities suggested that MLPs may also influence
47
48
49 functions besides aminoacyl-AMP and aminoacyl-S-PCP formation. To investigate this
50
51 possibility, we reconstituted ENT biosynthesis in vitro to enable us to control for differences in
52
53
54
the Kd for MLP interactions with EntF, EntF solubility, and affinities of EntF for L-Ser. We
55
56 reconstituted ENT biosynthesis using prior studies by Walsh and colleagues as a guide.12 Briefly,
57
58
59
60
ACS Paragon Plus Environment 29
Page 31 of 48 Biochemistry

1
2
3
EntE, holo-EntB, holo-EntF, and saturating concentrations of the appropriate MLP were
4
5
6 incubated with saturating concentrations of substrates, 2,3-dihydroxybenzoate (DHB), ATP, and
7
8 L-Ser. In these reactions, the only limiting factor was how efficiently EntF functions, with or
9
10
11
without an MLP, when integrated into the complete ENT biosynthetic pathway. To detect ENT
12
13 production over time, the reaction was terminated by the addition of an aliquot of the reaction to
14
15 CAS reagent. CAS reagent loses its absorption at 630 nm when the iron is removed by a chelator
16
17
18 with a higher affinity for ferric iron28 providing a simple colorimetric assay for detecting ENT
19
20 biosynthesis.
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44 Figure 6. In vitro ENT biosynthesis by various EntF+MLP complexes monitored by CAS
45 absorbance. Assays were done in triplicate and represented as a mean with standard deviation.
46
47
48
49 A comparison of ENT biosynthesis by EntF+YbdZ versus EntF clearly showed a significant
50
51
52
increase in ENT production when YbdZ was present (Fig. 6). The failure of EntF to assemble
53
54 ENT at a level comparable to EntF+YbdZ even at saturating L-Ser concentrations suggested
55
56 EntF function was disrupted in more than just amino acid binding or L-Ser-S-EntF formation.
57
58
59
60
ACS Paragon Plus Environment 30
 Biochemistry Page 32 of 48

1
2
3
4
Thus, our prior proposal that the reason a ∆ybdZ strain of E. coli cannot grow in ILM is the
5
6 decreased affinity of EntF for L-Ser is likely incomplete.1 EntF+BSU31959, EntF+CmnN, and
7
8 EntF+VioN also failed to synthesize ENT at a rate comparable to EntF+YbdZ even at high L-Ser
9
10
11 concentrations (Fig. 6). While the reduced rate of L-Ser-S-PCP formation by EntF+BSU31959
12
13 may explain its reduced rate of ENT biosynthesis, the reduced rate of ENT production by
14
15
EntF+CmnN and EntF+VioN even at saturating levels of L-Ser suggest the NRPS is altered for
16
17
18 more than just a reduced affinity for the amino acid substrate. One possible reason for the
19
20 reduced rate of ENT production by EntF+CmnN and EntF+VioN is a reduced ability of these
21
22
23
noncognate complexes to condense DHB from EntB onto L-ser-S-EntF. Initial studies of the
24
25 ENT biosynthesis pathway indicate that the formation of (DHB-L-Ser)-S-EntF intermediates
26
27 occurs rapidly; therefore, monitoring the rate of DHB loading would require rapid quench
28
29
30 techniques.12 Instead, we tested whether these complexes are reduced in their ability to function
31
32 iteratively to generate the complete ENT cyclic trimer. We reasoned that if the enzyme
33
34 complexes stall in the middle of ENT formation, these intermediates would be hydrolyzed from
35
36
37 EntF and there would be a detectable build-up of intermediates in the reaction mixture. We used
38
39 LC/MS to detect and quantify the relative amounts of ENT along with monomer (DHB-L-Ser),
40
41
dimer (DHB-L-Ser)2, and trimer (DHB-L-Ser)3 intermediates. The amounts of ENT produced by
42
43
44 EntF, EntF+VioN, and EntF+CmnN were lower in comparison to the amount of ENT produced
45
46 by EntF+YbdZ as expected (Fig. 7). However, the levels of the biosynthetic intermediates were
47
48
49
all similarly reduced as well (Fig. S10, Table S5), suggesting the entire ENT biosynthetic
50
51 machinery is functioning a lower level when these noncognate MLPs are present.
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment 31
Page 33 of 48 Biochemistry

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22 Figure 7. (A) Comparison of ENT detection by LC/MS from in vitro reconstitution reactions
23 containing no MLP, YbdZ, CmnN or VioN. LC/MS was run in triplicate and area reported is
24 shown is the mean with standard deviation from triplicate samples. Values indicate the fold
25
26
decrease in ENT produced compared to samples containing YbdZ. Statistical analysis by
27 ANOVA indicates that ENT production in the presence of YbdZ is statistically distinct from
28 samples containing no MLP, CmnN and VioN (p= 0.0006).
29
30
31
32
33
34
35 The remaining three EntF+MLP complexes biosynthesized ENT at a rate comparable to
36
37
38 EntF+YbdZ.
39
40
41 Conclusions
42
43
44 The role MLPs play in NRPS enzymology has been an enigma since their initial discovery as a
45
46 potential ORF in the ENT biosynthesis gene cluster10 and the subsequent naming of the protein
47
48
49 superfamily after the eighth ORF in the mycobactin biosynthesis gene cluster.4 Results from the
50
51 original in vitro studies1–3 suggest that MLPs play a chaperone-like role in enabling proper
52
53
54
folding of the NRPS, specifically impacting the A domain. While there are some MLPs that
55
56 appear to function in a manner analogous to molecular chaperones, e.g. MbtH enabling enhanced
57
58
59
60
ACS Paragon Plus Environment 32
 Biochemistry Page 34 of 48

1
2
3
solubility of MbtB without being required for catalysis,14 many MLPs do not dissociate from the
4
5
6 NRPS once complexed with the NRPS suggesting they play a more active role in NRPS
7
8 enzymology.1,3,14
9
10
11 Here, we aimed to gain additional insights into MLP function by studying noncognate
12
13
14 NRPS+MLP complexes using the ENT NRPS system from E. coli (data summarized in Fig. 8).
15
16 We provide evidence that the enhanced solubility and catalysis that MLPs provide an NRPS are
17
18
19
separable functions in a manner distinct from those observed with MbtB+MbtH. PA2412 is able
20
21 to enhance EntF catalysis, but did not provide increased EntF solubility. In contrast, CmnN and
22
23 VioN both provided increased EntF solubility, but both failed to positively influence EntF
24
25
26 catalysis. How these differences occur is not evident at this time even when amino acid sequence
27
28 comparisons, in vivo and in vitro data, and high-resolution structure of EntF+PA241213 are
29
30 combined. Directed evolution studies to evolve the NRPS+MLP interactions and evolve A
31
32
33 domains to function independent of an MLP are on-going and may provide more insight into
34
35 these questions.
36
37
38 To date, all analyses of NRPS+MLP interactions have focused on the impact MLPs have on
39
40
41 amino acid activation by A domains. Here we have provided the first evidence that improper
42
43 NRPS+MLP interactions can negatively impact not only amino acid activation, but also
44
45 aminoacyl-S-PCP formation (Fig. 5), along with the overall function of the NRPS (Fig. 7).
46
47
48 When these data are combined with the solubility data, they suggest that simple assessments of
49
50 NRPS+MLP interactions based solely on enhanced solubility or amino acid activation may not
51
52
provide the necessary information to conclude a properly functioning NRPS+MLP interaction is
53
54
55 occurring.
56
57
58
59
60
ACS Paragon Plus Environment 33
Page 35 of 48 Biochemistry

1
2
3
These conclusions raise important issues for the long-term goals of generating fully functional
4
5
6 chimeric NRPSs. Improper NRPS+MLP pairings may negatively impact NRPS enzymology in
7
8 unexpected ways as summarized in Fig. 8. For example, the introduction of an NRPS module or
9
10
11
A domain along with its partner MLP may not solve the MLP-dependence problem due to
12
13 complications that arise from noncognate pairings from both native and introduced NRPS+MLP
14
15 systems. Overcoming these obstacles will require a better understanding of MLP+NRPS
16
17
18 specificity, the ability to convert an MLP-dependent NRPS to one that is MLP-independent, or
19
20 the discovery of a universal MLP that functions with all NRPSs in a manner analogous to the
21
22 universal phosphopantetheinyltransferase Sfp. On-going studies in our laboratory are addressing
23
24
25 each of these research directions.
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47 Figure 8. Summary of results for each noncognate MLP interaction with EntF. This heat map
48 summarizes the results from the various assays scored from worse than EntF to equivalent to
49 EntF+YbdZ. n/a = not applicable.
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment 34
 Biochemistry Page 36 of 48

1
2
3
4
5
6
7 AUTHOR INFORMATION
8
9
10 Corresponding Author
11
12
13
* Contact information for the author to whom correspondence should be addressed. Phone: (608)
14
15 263-9075 Email: michael.thomas@wisc.edu
16
17
18 Author Contributions
19
20
21 The manuscript was written through contributions of all authors. All authors have given approval
22
23 to the final version of the manuscript.
24
25
26
27 Funding Sources
28
29 This work was funded by the National Institutes of Health grant G100346.
30
31
32
33 ACKNOWLEDGMENT
34
35 We thank Dr. Bradon MacDonald for technical assistance with phylogenetic modeling. Dr.
36
37 Philipp Wiemann for invaluable technical assistance obtaining LC/MS data. Dr. Jade Wang for
38
39
40 Bacillus subtilis 168. Dr. Lawrence Shimkets for Myxococcus xanthus DK1622. We thank Dr.
41
42 Matthew D. McMahon for the analysis of PvdL and PA2412.
43
44
45 ABBREVIATIONS
46
47 A, adenylation, PCP, peptidyl carrier protein, C, condensation, NRPS, nonribosomal peptide
48
49
synthetase, MLP, MbtH-like protein, ENT, enterobactin, iTOL, interactive tree of life, EDDHA,
50 ethylenediamine-N,N’-bis(2-hydroxyphenylacetic acid), TCEP, Tris-(2-carboxyethlyphosphine),
51 IPTG, Isopropyl β-D-1-thiogalactopyranoside, PAGE, polyacrylamide gel electrophoresis, TEV,
52 tobacco etch virus, DTT, dithiothreitol, FA, formic acid, CAS, Chrome azurol S, UHPLC, ultra-
53 high performance liquid chromatography, LC/MS, liquid chromatography/mass spectrometry.
54
55 SUPPORTING INFORMATION.
56
57
58
59
60
ACS Paragon Plus Environment 35
Page 37 of 48 Biochemistry

1
2
3
Anaylsis purified MLPs (Fig. S1), phylogenetic tree of MLPs (Fig. S2), immunoblot of tagged
4
5 MLPs (Fig. S3), growth after induction of MXAN_3118 (Fig. S4), co-purification of PvdL
6 A4PCP4/PA2412 (Fig S5), analysis of soluble MLPs in vivo (Fig. S6), kinetic analyses of EntF
7 (Figs. S7 and S8), co-purification of EntF/Atu3678 (Fig S9), LC-MS analysis of ENT
8 biosynthetic intermediates (Fig. S10 and Table S5), strains (Table S1), primer sequences (Table
9 S2), plasmids (Table S3) and gBlocks (Table S4).
10
11 REFERENCES
12
13
14 (1) Felnagle, E. A., Barkei, J. J., Park, H., Podevels, A. M., McMahon, M. D., Drott, D. W., and
15 Thomas, M. G. (2010) MbtH-like proteins as integral components of bacterial nonribosomal
16 peptide synthetases. Biochemistry 49, 8815–8817.
17
18 (2) Boll, B., Taubitz, T., and Heide, L. (2011) Role of MbtH-like proteins in the adenylation of
19 tyrosine during aminocoumarin and vancomycin biosynthesis. J. Biol. Chem. 286, 36281–36290.
20
21 (3) Zhang, W., Heemstra, J. R., Walsh, C. T., and Imker, H. J. (2010) Activation of the
22
23 pacidamycin PacL adenylation domain by MbtH-like proteins. Biochemistry 49, 9946–9947.
24
25 (4) Quadri, L. E., Sello, J., Keating, T. A., Weinreb, P. H., and Walsh, C. T. (1998) Identification
26 of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of
27 the virulence-conferring siderophore mycobactin. Chem. Biol. 5, 631–645.
28
29 (5) Ochsner, U. A., Wilderman, P. J., Vasil, A. I., and Vasil, M. L. (2002) GeneChip ®
30 expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of
31 novel pyoverdine biosynthesis genes. Mol. Microbiol. 45, 1277–1287.
32
33
(6) Wolpert, M., Gust, B., Kammerer, B., and Heide, L. (2007) Effects of deletions of mbtH-like
34
35 genes on clorobiocin biosynthesis in Streptomyces coelicolor. Microbiology 153, 1413–1423.
36
37 (7) Lautru, S., Oves-Costales, D., Pernodet, J. L., and Challis, G. L. (2007) MbtH-like protein-
38 mediated cross-talk between non-ribosomal peptide antibiotic and siderophore biosynthetic
39 pathways in Streptomyces coelicolor M145. Microbiology 153, 1405–1412.
40
41 (8) Chen, H., Hubbard, B. K., O’Connor, S. E., and Walsh, C. T. (2002) Formation of ß-hydroxy
42 histidine in the biosynthesis of nikkomycin antibiotics. Chem. Biol. 9, 103–112.
43
44 (9) Lauer, B., Russwurm, R., Schwarz, W., Kálmánczhelyi, A., Bruntner, C., Rosemeier, A., and
45
Bormann, C. (2001) Molecular characterization of co-transcribed genes from Streptomyces
46
47 tendae Tü901 involved in the biosynthesis of the peptidyl moiety and assembly of the peptidyl
48 nucleoside antibiotic nikkomycin. Mol. Gen. Genet. 264, 662–673.
49
50 (10) Pettis, G. S., and Mcintosh, M. A. (1987) Molecular characterization of the Escherichia Coli
51 Enterobactin cistron entF and coupled cxpression of entF and the fes gene. 169, 4154–4162.
52
53 (11) Reichert, J., Sakaitani, M., and Walsh, C. T. (1992) Characterization of EntF as a serine-
54 activating enzyme 1, 549–556.
55
56 (12) Gehring, A. M., Mori, I., and Walsh, C. T. (1998) Reconstitution and characterization of the
57
58
Escherichia coli enterobactin synthetase. Biochemistry 2960, 2648–2659.
59
60
ACS Paragon Plus Environment 36
 Biochemistry Page 38 of 48

1
2
3
(13) Miller, B. R., Drake, E. J., Shi, C., Aldrich, C. C., and Gulick, A. M. (2016) Structures of a
4
5 nonribosomal peptide synthetase module bound to MbtH-like proteins support a highly dynamic
6 domain achitecture. J. Biol. Chem. 291, 22559–22571.
7
8 (14) McMahon, M. D., Rush, J. S., and Thomas, M. G. (2012) Analyses of MbtB, MbtE, and
9 MbtF suggest revisions to the mycobactin biosynthesis pathway in Mycobacterium tuberculosis.
10 J. Bacteriol. 194, 2809–2818.
11
12 (15) Herbst, D. a, Boll, B., Zocher, G., Stehle, T., and Heide, L. (2013) Structural basis of the
13
interaction of MbtH-like proteins, putative regulators of nonribosomal peptide biosynthesis, with
14
15 adenylating enzymes. J. Biol. Chem. 288, 1991–2003.
16
17 (16) Drake, E. J., Miller, B. R., Shi, C., Tarrasch, J. T., Sundlov, J. A., Leigh Allen, C., Skiniotis,
18 G., Aldrich, C. C., and Gulick, A. M. (2016) Structures of two distinct conformations of holo-
19 non-ribosomal peptide synthetases. Nature 529, 235–238.
20
21 (17) Tarry, M. J., Haque, A. S., Bui, K. H., and Schmeing, T. M. (2017) X-Ray crystallography
22 and electron microscopy of synthetase proteins reveal a flexible architecture. Structure. 25, 783–
23
793.
24
25
(18) Konz, D., and Marahiel, M. A. (1999) How do peptide synthetases generate structural
26
27 diversity? Chem. Biol. 6, R39–R48.
28
29 (19) Hamilton, C. M., Aldea, M., Washburn, B. K., Babitzke, P., and Kushner, S. R. (1995) New
30 method for generating deletion and gene replacements in Eschericha coli. J. Bacteriol. 171,
31 4617–4622.
32
33 (20) Klock, H. E., Koesema, E. J., Knuth, M. W., and Lesley, S. A. (2008) Combining the
34 polymerase incomplete primer extension method for cloning and mutagenesis with
35
microscreening to accelerate structural genomics efforts. Proteins Struct. Funct. Genet. 71, 982–
36
37 994.
38
39 (21) Guzman, L., Belin, D., and Carson, M. J. (1995) Tight regulation, modulation, and high-
40 level expression by vectors containing the arabinose pBAD promoter. J. Bacteriol. 177, 4121–
41 4130.
42
43 (22) Rocco, C. J., Dennison, K. L., Klenchin, V. a, Rayment, I., and Escalante-Semerena, J. C.
44 (2008) Construction and use of new cloning vectors for the rapid isolation of recombinant
45
proteins from Escherichia coli. Plasmid 59, 231–237.
46
47
48
(23) Huang, Y., Niu, B., Gao, Y., Fu, L., and Li, W. (2010) CD-HIT Suite: a web server for
49 clustering and comparing biological sequences. Bioinformatics 26, 680–682.
50
51 (24) Katoh, K., and Standley, D. M. (2013) MAFFT Multiple Sequence Alignment Software
52 Version 7: Improvements in performance and usability article fast track. Mol. Biol. Evol. 30,
53 772–780.
54
55 (25) Price, M. N., Dehal, P. S., and Arkin, A. P. (2010) FastTree 2– Approximately maximum-
56 likelihood trees for large alignments. PLoS One 5, e9490.
57
58
59
60
ACS Paragon Plus Environment 37
Page 39 of 48 Biochemistry

1
2
3
(26) Letunic, I., and Bork, P. (2007) Interactive Tree Of Life (iTOL): an online tool for
4
5 phylogenetic tree display and annotation. Bioinformatics 23, 127–128.
6
7 (27) Chan, Y. A., and Thomas, M. G. (2009) Formation and characterization of acyl carrier
8 protein–linked polyketide synthase extender units, in Complex Enzymes in Microbial Natural
9 Product Biosynthesis, Part B: Polyketides, Aminocoumarins and Carbohydrates 1st ed., pp 143–
10 163. Elsevier Inc.
11
12 (28) Schwyn, B., and Neilands, J. B. (1987) Universal chemical assay for the detection and
13
determination of siderophores. Anal. Biochem. 160, 47–56.
14
15
16
(29) Melamud, E., Vastag, L., and Rabinowitz, J. D. (2010) Metabolomic analysis and
17 visualization engine for LC-MS data. Anal. Chem. 82, 9818–9826.
18
19 (30) Rondon, M. R., Ballering, K. S., and Thomas, M. G. (2004) Identification and analysis of a
20 siderophore biosynthetic gene cluster from Agrobacterium tumefaciens C58. Microbiology 150,
21 3857–3866.
22
23 (31) May, J., Wendrich, T. M., Marahiel, M. A., and I, K. A. (2001) The dhb operon of Bacillus
24 subtilis encodes the biosynthetic template for the catecholic siderophore 2,3-dihydroxybenzoate-
25
26
glycine-threonine trimeric ester bacillibactin. J. Biol. Chem. 276, 7209–7217.
27
28
(32) Müller, S., Willett, J. W., Bahr, S. M., Darnell, C. L., Hummels, K. R., Dong, C. K.,
29 Vlamakis, H. C., and Kirby, J. R. (2013) Draft genome sequence of Myxococcus xanthus wild-
30 type strain DZ2, a model organism for predation and development. Genome Announc. 1, e00217-
31 13.
32
33 (33) Thomas, M. G., Chan, Y. A., Ozanick, S. G., and Al, T. E. T. (2003) Deciphering
34 tuberactinomycin biosynthesis: isolation, sequencing, and annotation of the viomycin
35
biosynthetic gene cluster. Antimicrob. Agents Chemother. 47, 2823–2830.
36
37
38
(34) Felnagle, E. A., Rondon, M. R., Berti, A. D., Crosby, H. A., and Thomas, M. G. (2007)
39 Identification of the biosynthetic gene cluster and an additional gene for resistance to the
40 antituberculosis drug capreomycin. Appl. Environ. Microbiol. 73, 4162–4170.
41
42 (35) Heemstra, J. R., Walsh, C. T., and Sattely, E. S. (2009) Enzymatic tailoring of ornithine in
43 the biosynthesis of the Rhizobium cyclic trihydroxamate siderophore vicibactin. J. Am. Chem.
44 Soc. 131, 15317–15329.
45
46 (36) Bennett, B. D., Kimball, E. H., Gao, M., Osterhout, R., Dien, S. J. Van, and Rabinowitz, J.
47
48
D. (2009) Absolute metabolite concentrations and implied enzyme active site occupancy in
49 Escherichia coli. Nat. Chem. Biol. 5, 593–599.
50
51 (37) Shaw-Reid, C. A., Kelleher, N. L., Losey, H. C., Gehring, A. M., Berg, C., and Walsh, C. T.
52 (1999) Assembly line enzymology by multimoldular nonribosomal peptide synthetases: the
53 thioesterase domain of E. coli EntF catalyzes both elongation and cyclolactonization. Chem.
54 Biol. 6, 385–400.
55
56
57
58
59
60
ACS Paragon Plus Environment 38
 Biochemistry Page 40 of 48

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16 For Table of Contents use only:
17
18
19
20 Characterization of the functional variance of MbtH-like protein interaction with a nonribosomal
21 peptide synthetase.
22
23 Rebecca A. Schomer and Michael G. Thomas
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment 39
Page 41 of 48 Biochemistry

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Figure 1. Schematic of ENT NRPS domain structure. Light blue circles represent NRPS domains, the red circle
20 represents YbdZ, the MLP of the ENT system. Abbreviations: A, adenylation; PCP, peptidyl carrier protein; C,
21 condensation; Te, thioesterase.
22
23
24 90x32mm (300 x 300 DPI)
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
 Biochemistry Page 42 of 48

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
Figure 2. Analysis of complementation for ∆ybdZ by various noncognate MLPs. Growth curves for strains
34
containing pBAD33 with No MLP, cmnN or vioN are superimposed along the baseline. Data shown are means
35 of triplicate, independent samples with standard deviation shaded.
36
37
38 82x66mm (300 x 300 DPI)
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
Page 43 of 48 Biochemistry

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26 Figure 3. (A) MLP amino acid sequence alignments. Residues implicated in protein-protein interactions from
27 structural studies of EntF/MLP complexes (pink) and didomain (MLP-adenylation domain) SlgN1 (green) are
28 highlighted. (B) Amino acid identity (upper tier) and amino acid similarity (lower tier) comparisons for the
29 MLPs included in this study.
30
31 165x92mm (300 x 300 DPI)
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
 Biochemistry Page 44 of 48

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29 Figure 4. Analysis of EntF solubility when co-overproduced with MLPs. Equal amounts of total protein (75 µg)
30 were loaded for each sample on a SDS-PAGE (10% polyacrylamide) gel and stained with Coomassie blue.
31 This gel is representative of multiple experimental replicates.
32
33
34 54x36mm (600 x 600 DPI)
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
Page 45 of 48 Biochemistry

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36 Figure 5: Formation of [14C]-L-Seryl-S-EntF after 40 minutes of incubation at RT. EntF was
37 phosphopantetheinylated in vitro prior to incubation with [14C]-L-Ser and MLPs. Data shown are the means
38 with standard deviation from triplicate assays. Asterisk indicates statistically significant difference
39 (p=0.0194) using an unpaired t-test. ANOVA statistical analysis also indicated a statistically relevant result.
40
41 82x71mm (300 x 300 DPI)
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
 Biochemistry Page 46 of 48

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Figure 6. In vitro ENT biosynthesis by various EntF+MLP complexes monitored by CAS absorbance. Assays
37 were done in triplicate and represented as a mean with standard deviation.
38
39
40 82x73mm (300 x 300 DPI)
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
Page 47 of 48 Biochemistry

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 Figure 7. (A) Comparison of ENT detection by LC/MS from in vitro reconstitution reactions containing no
33 MLP, YbdZ, CmnN or VioN. LC/MS was run in triplicate and area reported is shown is the mean with standard
34 deviation from triplicate samples. Values indicate the fold decrease in ENT produced compared to samples
35 containing YbdZ. Statistical analysis by ANOVA indicates that ENT production in the presence of YbdZ is
36 statistically distinct from samples containing no MLP, CmnN and VioN (p= 0.0006).
37
38 82x61mm (300 x 300 DPI)
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
 Biochemistry Page 48 of 48

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35 Figure 8. Summary of results for each noncognate MLP interaction with EntF. This heat map summarizes the
36 results from the various assays scored from worse than EntF to equivalent to EntF+YbdZ. n/a = not
applicable
37
38 68x57mm (600 x 600 DPI)
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment